Nitawaki, T., Sakata, Y., Kawamura, K., & Ichikado, K. (2017). Case report: Continued treatment with alectinib is possible for patients with lung adenocarcinoma with drug-induced interstitial lung disease. BMC Pulm Med.
Styl ChicagoNitawaki, Tatsuya, Yoshihiko Sakata, Kodai Kawamura, a Kazuya Ichikado. "Case Report: Continued Treatment With Alectinib Is Possible for Patients With Lung Adenocarcinoma With Drug-induced Interstitial Lung Disease." BMC Pulm Med 2017.
Citace podle MLANitawaki, Tatsuya, Yoshihiko Sakata, Kodai Kawamura, a Kazuya Ichikado. "Case Report: Continued Treatment With Alectinib Is Possible for Patients With Lung Adenocarcinoma With Drug-induced Interstitial Lung Disease." BMC Pulm Med 2017.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..